Skip to main content

Table 2 Crude and adjusted odds of double treatment failure compared to treatment success

From: Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial

Baseline characteristic

Crude odds ratio

(95% CI)

Adjusted odds ratio

(95% CI)

P-Value

Age

0.97 (0.94, 1.01)

0.97 (0.94, 1.0)

0.086

Sex

ā€ƒMale

Reference

Reference

Ā 

ā€ƒFemale

1.4 (0.5, 3.8)

3.0 (0.82, 11)

0.098

Anatomic location

ā€ƒPosterior/Panuveitis

Reference

Reference

Ā 

ā€ƒAnterior/Intermediate

4.5 (1.7, 12)

2.6 (0.81, 8.3)

0.11

CME

ā€ƒNo

Reference

Reference

0.15

ā€ƒYes

3.4 (1.3, 8.7)

2.3 (0.74, 7.3)

Ā 

Retinal vasculitis

ā€ƒNo

Reference

Reference

Ā 

ā€ƒYes

8.1 (1.8, 36)

8.6 (1.6, 47)

0.014

ā€ƒFA not done

3.9 (1.2, 13)

2.8 (0.77, 10)

0.12